Analysis of a publicly available dataset of Sunitinib resistance in a renal cancer PDX model36 also demonstrated up-regulation of core FOXC2-target genes specifically in the human/tumor compartment (Fig 6D) upon Sunitinib resistance. The gene discussed is FOXC2; the disease is renal carcinoma.